MaxCyte Signs Strategic Platform License with Imugene to Adv

Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T product candidate for the treatment of blood...

Related Keywords

United Kingdom , Australia , North Carolina , United States , Rockville , Western Australia , Sydney , New South Wales , Mary Jane Elliott , Panmure Gordon , Rupert Dearden , David Deuchler , Chris Welsh , Matt Wright , Maher Masoud , Youtube Imugenelimited , Emma Earl Freddy Crossley , Leslie Chong , Imugene Limited Contacts , Gilmartin Group , Maxcyte Inc , Linkedin , Twitter , Nasdaq , Linkedin Imugene , Flow Electroporation , Precision Biosciences , Managing Director , Cyte Contacts , Joint Corporate , Limited Contacts , Chief Executive , Markets ,